On April 1, 2011 we will add the brand-name drugs Colcrys, Creon, Invega Sustenna, Pancreaze and Tribenzor to the BlueCross Preferred Drug List. Beginning April 1, members with three or four-tier plans who use these drugs will pay the preferred copayment or coinsurance for any prescriptions they receive.To learn more about the BlueCross Preferred Drug List, visit the Prescription Drug Information page on our website and select the Preferred Drug List link.
We will also add a quantity limit for the brand-name drugs Abstral and Butrans to our Quantity Management program. Beginning April 1, we will limit Abstral coverage to 120 tablets per month. We will limit Butrans coverage to four patches per month. Members who need more Abstral and Butrans than their coverage allows should talk to their doctors about their options. To learn more about the Quantity Management program, visit the Prescription Drug Information page on our website and select the Drug Management link. Then select the Quantity Limit Drug List link.